Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Authors

Jennifer B. Green
M. Angelyn BethelFollow
Paul W. Armstrong
John B. Buse
Samuel S. Engel
John M. Lachin, George Washington UniversityFollow
+13 additional authors

Document Type

Journal Article

Publication Date

6-2015

Journal

New England Journal of Medicine

Inclusive Pages

Cardiovascular Diseases--complications; Diabetes Mellitus, Type 2--drug therapy; Hypoglycemic Agents--adverse effects; Pyrazines--adverse effects; Triazoles--adverse effects

APA Citation

[Epub ahead of print]

Peer Reviewed

1